Lv3
280 积分 2021-01-03 加入
Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation
4天前
已关闭
Approaching a therapeutic inflection point for FLT3-mutated AML
4天前
已关闭
Approaching a therapeutic inflection point for FLT3-mutated AML
4天前
已关闭
Measurable residual disease monitoring in AML: Prospects for therapeutic decision‐making and new drug development
20天前
已完结
A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)
20天前
已关闭
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
20天前
已完结
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor
20天前
已完结
Dasatinib maintenance following allogeneic transplantation in acute myeloid leukemia with KIT mutation
20天前
已完结
How I Treat Older Patients with Ph/BCR-ABL-Negative Acute Lymphoblastic Leukemia
1个月前
已关闭
The biology and function of extracellular vesicles in immune response and immunity
2个月前
已完结
皖公网安备34019202002308
